BioSig Technologies Closes Public Offering of Shares

BioSig Technologies ( (BSGM) ) has shared an update.

On August 13, 2025, BioSig Technologies entered into an Underwriting Agreement with Clear Street LLC and Needham & Company, LLC to sell 3,852,149 shares of common stock in a public offering, which closed on August 15, 2025. The offering, priced at $3.90 per share, is expected to generate approximately $15.02 million in gross proceeds, intended for purchasing gold bullion, working capital, and general corporate purposes. The agreement includes customary lock-up provisions and indemnification obligations, impacting the company’s financial strategy and market positioning.

The most recent analyst rating on (BSGM) stock is a Buy with a $2.75 price target. To see the full list of analyst forecasts on BioSig Technologies stock, see the BSGM Stock Forecast page.

Spark’s Take on BSGM Stock

According to Spark, TipRanks’ AI Analyst, BSGM is a Underperform.

BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.

To see Spark’s full report on BSGM stock, click here.

More about BioSig Technologies

BioSig Technologies, Inc. is a medical device technology company specializing in advanced digital signal processing technology for cardiovascular arrhythmias, with its PURE EP™ Platform aiding electrophysiologists in ablation treatments. Streamex, a wholly owned subsidiary, focuses on RWA and gold tokenization, aiming to integrate the gold market with blockchain technology.

Average Trading Volume: 1,174,511

Technical Sentiment Signal: Buy

Current Market Cap: $159.8M

Learn more about BSGM stock on TipRanks’ Stock Analysis page.